ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ICCC Company Profile and Key Details

NASDAQ : ICCC

ImmuCell Corporation

$5.50

0.01+0.18%

At Close 4:00 PM

61.76

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

ImmuCell Corporation (ICCC) stock surged +0.18%, trading at $5.50 on NASDAQ, up from the previous close of $5.49. The stock opened at $5.55, fluctuating between $5.38 and $5.55 in the recent session.

Stock Snapshot

5.49

Prev. Close

5.55

Open

49.4M

Market Cap

8.98M

Number of Shares

5.3833

Day Low

5.55

Day High

-21.15

P/E Ratio

71.56%

Free Float in %

-0.26

EPS (TTM)

N/A

Book Value

-1.1

Cash Flow per Share

4.08K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 17, 2025	5.55	5.55	5.38	5.50	4.08K
Apr 16, 2025	5.23	5.55	5.23	5.49	39.64K
Apr 15, 2025	5.49	5.55	5.20	5.39	65.6K
Apr 14, 2025	5.50	5.55	5.15	5.50	144.31K
Apr 11, 2025	5.00	5.55	5.00	5.41	128.25K
Apr 10, 2025	5.02	5.34	4.85	5.07	93.6K
Apr 09, 2025	4.91	5.23	4.63	4.93	20.74K
Apr 08, 2025	5.14	5.38	4.76	4.81	35.13K
Apr 07, 2025	5.29	5.40	5.11	5.38	13.74K
Apr 04, 2025	5.30	5.72	5.30	5.36	24.37K
Apr 03, 2025	5.42	5.68	5.32	5.38	20.72K
Apr 02, 2025	5.30	5.50	5.20	5.42	24.71K
Apr 01, 2025	5.08	5.50	4.82	5.00	77.27K
Mar 31, 2025	4.96	5.15	4.79	4.79	9.85K
Mar 28, 2025	5.00	5.04	4.71	5.01	9.89K
Mar 27, 2025	4.86	5.05	4.56	4.90	36.2K
Mar 26, 2025	4.93	4.93	4.78	4.78	5.14K
Mar 25, 2025	4.82	4.93	4.82	4.85	12.84K
Mar 24, 2025	4.95	4.95	4.89	4.94	1.43K
Mar 21, 2025	5.00	5.00	4.81	4.91	18.63K

Contact Details

Portland, ME 04103

United States

Website: https://immucell.comContact: 207 878 2770

About Company

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

Frequently Asked Questions

What is the current ImmuCell Corporation (ICCC) stock price?

ImmuCell Corporation (NASDAQ: ICCC) stock price is $5.50 in the last trading session. During the trading session, ICCC stock reached the peak price of $5.55 while $5.38 was the lowest point it dropped to. The percentage change in ICCC stock occurred in the recent session was 0.18% while the dollar amount for the price change in ICCC stock was $0.01.

ICCC's industry and sector of operation?

The NASDAQ listed ICCC is part of Biotechnology industry that operates in the broader Healthcare sector. ImmuCell Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ICCC?

John W. Zinckgraf
Director of Product Devel.
Ms. Elizabeth L. Williams
Vice President of Manufacturing Operations
Mr. Michael F. Brigham
Pres, Chief Executive Officer, Principal Financial Officer, Treasurer, Sec. & Director
Ms. Bobbi Jo Brockmann
Vice President of Sales & Marketing and Director
Elizabeth S. Toothaker
Director of Fin. & Admin.
Mr. A. Gustavo Scaffa
Senior Director of Quality

How ICCC did perform over past 52-week?

ICCC's closing price is 64.67% higher than its 52-week low of $3.34 where as its distance from 52-week high of $5.82 is -5.5%.

How many employees does ICCC have?

Number of ICCC employees currently stands at 69.

Link for ICCC official website?

Official Website of ICCC is: https://immucell.com

How do I contact ICCC?

ICCC could be contacted at phone 207 878 2770 and can also be accessed through its website. ICCC operates from 56 Evergreen Drive, Portland, ME 04103, United States.

How many shares of ICCC are traded daily?

ICCC stock volume for the day was 4.08K shares. The average number of ICCC shares traded daily for last 3 months was 17.29K.

What is the market cap of ICCC currently?

The market value of ICCC currently stands at $49.40M with its latest stock price at $5.50 and 8.98M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

News

Investing Crypto Market Business US Stocks

Useful Links

Screener Market Data Insider Transactions Upgrades & Downgrades 52 Week Highs & Lows Unusual Volume Dividend Calendar Earnings Calendar

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	69
Beta	0.39
Sales or Revenue	$17.47M
5Y Sales Change%	0.133%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology